BeiGene, Ltd, a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to BRUKINSA® (zanubrutinib) for the...
MBrace Therapeutics, a clinical-stage biopharmaceutical company devoted to improving the lives of patients with cancer by developing novel antibody-drug conjugates (ADCs), announced the appointment...
Velsera, a pioneering entity in the field of computational biology with a focus on advancing precision medicine, is delighted to formally announce the appointment...
Anagenex, a pioneering drug discovery company pairing large-scale data generation with proprietary artificial intelligence (AI) to discover the next generation of small molecule medicines,...
OncoNano Medicine, Inc., announced the appointment of Dr. Kartik Krishnan, MD, PhD to Chief Executive Officer (CEO) and member of the Board of Directors....
